Argentina is industry's "number one problem" in trade -- PhRMA's Bale.
Executive Summary
ARGENTINA TRADE INVESTIGATION CLOSURE OPPOSED BY PhRMA, Pharmaceutical Research & Manufacturers of America Senior VP-International Harvey Bale, PhD, said at a May 1 press briefing in Washington, D.C. Bale reported that the industry is "less than enthusiastic" about the U.S. decision not to conduct further investigations of Argentina, which he said is the drug industry's "number one global problem."